TargetTrack | Target Query Results

1 targets match your request

Target ID:NYSGRC-019589
Source Organism
Chromobacterium violaceum ATCC 12472
Target Name
probable atrazine chlorohydrolase [Chromobacterium violaceum ATCC 12472]
Target Category
community nominated
Status
in PDB
Site
NYSGRC
Site ID
019589
Lab List
AECOM
Structure available
4F0R, 4F0S
URL
http://kiemlicz.med.virginia.edu/...
Last Update
2012-02-29
Project List
PSI-3
Database References
NYSGRC: 019589, GenBank: 34102341, NCBI RefSeq: AAQ58707.1


Targets that contain a matching or similar sequence to your query are listed with the best alignments presented at the top. View the Alignment tab to see how closely a target sequence matches your query.

A target containing one or more sequences may have multiple alignments in this tab.

The Summary tab contains target-level information about a target in your search query.

The Sequence tab contains information about all the sequences defined within a target.

Links to additional annotation sources are provided for each protein sequence, as well as derived protein properties and domain annotations.

The Progress tab contains any trial-level data provided for the target.

Trials are ordered by experimental progress, with the most advanced trials listed first.

The protocols used in each trial are listed by experimental type. A green plus sign indicates protocol details specific to that trial can be found in the protocol summary page.

The Summary tab contains target-level information about a target in your search query.

The Sequence tab contains information about all the sequences defined within a target.

Links to additional annotation sources are provided for each protein sequence, as well as derived protein properties and domain annotations.

The Progress tab contains any trial-level data provided for the target.

Trials are ordered by experimental progress, with the most advanced trials listed first.

The protocols used in each trial are listed by experimental type. A green plus sign indicates protocol details specific to that trial can be found in the protocol summary page.